Carasil and htra1: an early adulthood syndrome

Authors

  • Sneha Susan Samuel Nirmala College of Pharmacy, Kerala University of Health & Science, Muvattupuzha Kerala, India
  • Bharat Mishra Rameshwaram Institute of Technology & Management, Lucknow, Uttar Pradesh, India.
  • Nadheem Muhammad Shajeef Nirmala College of Pharmacy, Kerala University of Health & Science, Muvattupuzha Kerala, India

DOI:

https://doi.org/10.37022/jpmhs.v4i3.26

Keywords:

Arteriopathy, Leukoencephalopathy, Binswanger’s disease, Mutation, polymorphism

Abstract

Cerebral Autosomal Recessive Arteriopathy Subcortical Infracts Leukoencephalopathy (CARASIL), is an autosomal recessive disorder inherited by two copies of an abnormal gene from some trait, one from each parent. Person with this disorder may have a change in deep white matter in brain; and this disorder can be characterized by damage to small blood vessels in brain. Increasing muscle tone, slurred speech, stiff movement of legs, gait disturbance, spondylosis, sparse hair are the major symptoms. But the ultimate cause of this disorder can lead to loss of memory, cognitive impairment. This disorder can be caused in early adulthood i.e., between 20-40 years of age. CARASIL has first reported in Japan, later occurred in China and Caucasian population. A neurological disorder named Binswanger’s disease (BD) and chronic immunological disorder multiple sclerosis are main different alternation of this disease. Mutation requires the high temperature resultant, A serine peptidase 1 causes CARASIL, so it is a serine protease.

Serine protease HTRA1 is an enzyme that in humans is encoded by HTRA1 gene. HTRA1 protein is composed of four distinct protein domains. This is located on the long (q) arm of chromosome 10 in a region known as 10q26. This protein is a secreted enzyme that is proposed to regulate the availability of insulin like growth factors (IGF) by cleaving IGF binding proteins. HTRA1 enzyme helps breakdown many other kinds of proteins in this space surrounding cells (extracellular matrix). This is attached to protein in Transforming Growth Factor Beta (TGF-beta) and slows down their ability to send chemical signals. Variant known as rs11200638 is found in an area of gene called promoter region which starts the production HTRA1 enzyme. It is unclear how of polymorphism in the HTRA1 gene might be an age-related macular degeneration.

So at last, we can conclude that CARASIL is related to brain inherited from the abnormal genes caused to small arteries and to the specific area of deep brain in higher function; tissue loss due to lack of oxygen where small arteries get blocked destruction to myelin an oily substance covers and protects the nerve fibers in CNS. 

Downloads

Download data is not yet available.

References

https://rarediseases.info.nih.gov/diseases/pages/31/faqs-about-rare-diseases

Herve D, Chabriat H. CADASIL. J Geriatr Psychiatry Neurol. 2010.Dec;23(4):269-76.

HTRA1 gene, HtrA serine peptidase https://medlineplus.gov/genetics/gene/htra1/#references

National Organisation of Rare dosorders (NORD). Acquired Neuromyotonia https://rarediseases.org/rare-diseases/acquired-neuromyotonia/

Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. Journal of Stroke and Cerebrovascular Diseases. 2011 Mar 1;20(2):85-93.

Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Annals of the New York Academy of Sciences. 2008 Oct;1142:266.

Arima K, Yanagawa S, Ito N, Ikeda S. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology. 2003;23:327-334

Onodera O, Nozaki H, Fukutake T. HTRA1 disorder.

Love S. Demyelinating diseases. Journal of clinical pathology. 2006 Nov 1;59(11):1151-9.

Müller SJ, Khadhraoui E, Allam I, Argyriou L, Hehr U, Liman J, Hasenfuß G, Bähr M, Riedel CH, Koch JC. CARASIL with coronary artery disease and distinct cerebral microhemorrhage: A case report and literature review. Clinical and Translational Neuroscience. 2020 Mar 24;4(1):2514183X20914182.

Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006 Jul 1;92(7):987-93.

Yaashwant P, Chandrakala B, Govindarajan Sumathy BS. Stickler Syndrome–A Review. European Journal of Molecular & Clinical Medicine. 2020 Dec 16;7(10):582-6.

Yu Z, Cao S, Wu A, Yue H, Zhang C, Wang J, Xia M, Wu J. Genetically Confirmed CARASIL: Case Report With Novel HTRA1 Mutation and Literature Review. World Neurosurgery. 2020 Nov 1;143:121-8.

Rare diseases: rare disease treatments and research. Advances in rare diseases. https://www.pfizer.com/science/rare-diseases

Organization of rare diseases. https://ordindia.in/about-rd/rare-disease-definition/

Müller SJ, Khadhraoui E, Allam I, Argyriou L, Hehr U, Liman J, Hasenfuß G, Bähr M, Riedel CH, Koch JC. CARASIL with coronary artery disease and distinct cerebral microhemorrhage: A case report and literature review. Clinical and Translational Neuroscience. 2020 Mar 24;4(1):2514183X20914182.

Ibrahimi M, Nozaki H, Lee A, Onodera O, Reichwein R, Wicklund M, El-Ghanem M. A CARASIL patient from Americas with novel mutation and atypical features: case presentation and literature review. Cerebrovascular Diseases. 2017;44(3-4):135-40.

Ziaei A, Xu X, Dehghani L, Bonnard C, Zellner A, Ng AY, Tohari S, Venkatesh B, Haffner C, Reversade B, Shaygannejad V. Novel mutation in HTRA1 in a family with diffuse white matter lesions and inflammatory features. Neurology Genetics. 2019 Aug 1;5(4).

An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3379-86. doi: 10.1167/iovs.09-4853. Epub 2010 Mar 5.

Di Donato I, Bianchi S, Gallus GN, Cerase A, Taglia I, Pescini F, Nannucci S, Battisti C, Inzitari D, Pantoni L, Zini A. Heterozygous mutations of HTRA 1 gene in patients with familial cerebral small vessel disease. CNS neuroscience & therapeutics. 2017 Sep;23(9):759-65.

Uemura M, Nozaki H, Koyama A, Sakai N, Ando S, Kanazawa M, Kato T, Onodera O. HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade. Frontiers in neurology. 2019 Jun 28;10:693.

Lee YC, Chung CP, Chao NC, Fuh JL, Chang FC, Soong BW, Liao YC. Characterization of heterozygous HTRA1 mutations in Taiwanese patients with cerebral small vessel disease. Stroke. 2018 Jul;49(7):1593-601.

https://www.researchgate.net/figure/Figure-Typical-clinical-and-neuroimaging-features-of-CARASIL-Axial-brain-MRI-disclosing_fig1_305694183

https://www.semanticscholar.org/paper/Cerebral-autosomal-recessive-arteriopathy-with-and-Fukutake/1160474c98a75cb7f509c5ec1ebc6152c7eed8ae

https://www.semanticscholar.org/paper/Mutation-in-the-HTRA1-gene-in-a-patient-with-spine-Bayrakl%C4%B1-Balaban/ebb99b685390f8d5f4c7513ee6a08899ef040ae0

https://onlinelibrary.wiley.com/doi/10.1111/bpa.12181

Published

2021-09-30

How to Cite

Samuel, S. S., B. Mishra, and N. M. Shajeef. “Carasil and htra1: An Early Adulthood Syndrome”. UPI Journal of Pharmaceutical, Medical and Health Sciences, vol. 4, no. 3, Sept. 2021, pp. 13-17, doi:10.37022/jpmhs.v4i3.26.

Issue

Section

Case Studie(s)

Citations